|
CA2101337A1
(en)
|
1991-02-01 |
1992-08-02 |
Stephan D. Glenn |
Method of producing f(ab')2 fragments of immunoglobulins
|
|
US6090382A
(en)
|
1996-02-09 |
2000-07-18 |
Basf Aktiengesellschaft |
Human antibodies that bind human TNFα
|
|
DE122004000004I1
(de)
|
1996-02-09 |
2004-08-12 |
Abott Biotechnology Ltd |
Humane Antikörper welche an Humanen TNFalpha binden.
|
|
ES2292682T3
(es)
|
1998-05-06 |
2008-03-16 |
Genentech, Inc. |
Purificacion de anticuerpos mediante cromatografia de intercambio ionico.
|
|
CA2385745C
(en)
|
2001-06-08 |
2015-02-17 |
Abbott Laboratories (Bermuda) Ltd. |
Methods of administering anti-tnf.alpha. antibodies
|
|
AR040603A1
(es)
|
2002-07-19 |
2005-04-13 |
Abbott Lab S A |
El uso de un anticuerpo anti-tnfalfa neutralizador de alta afinidad en la fabricacion de un medicamento y conjunto de elementos
|
|
US20040033228A1
(en)
|
2002-08-16 |
2004-02-19 |
Hans-Juergen Krause |
Formulation of human antibodies for treating TNF-alpha associated disorders
|
|
MY150740A
(en)
|
2002-10-24 |
2014-02-28 |
Abbvie Biotechnology Ltd |
Low dose methods for treating disorders in which tnf? activity is detrimental
|
|
US8227241B2
(en)
|
2004-03-12 |
2012-07-24 |
Unigene Laboratories, Inc. |
Bacterial host cell for the direct expression of peptides
|
|
TWI439284B
(zh)
|
2004-04-09 |
2014-06-01 |
Abbvie Biotechnology Ltd |
用於治療ＴＮＦα相關失調症之多重可變劑量療法
|
|
WO2006096461A2
(en)
|
2005-03-08 |
2006-09-14 |
Pharmacia & Upjohn Company Llc |
Composition comprising an antibody against macrophage colony-stimulating factor (m-csf) and a chelating agent
|
|
AU2006246721B2
(en)
|
2005-05-16 |
2012-12-13 |
Abbvie Biotechnology Ltd |
Use of TNF inhibitor for treatment of erosive polyarthritis
|
|
EP1885847B1
(en)
|
2005-05-26 |
2011-07-06 |
Cytos Biotechnology AG |
Scalable fermentation process
|
|
JP5089582B2
(ja)
|
2005-06-07 |
2012-12-05 |
エスバテック、アン アルコン バイオメディカル リサーチ ユニット、エルエルシー |
ＴＮＦαを阻害する安定な可溶性抗体
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
US20070041905A1
(en)
|
2005-08-19 |
2007-02-22 |
Hoffman Rebecca S |
Method of treating depression using a TNF-alpha antibody
|
|
AR058140A1
(es)
|
2005-10-24 |
2008-01-23 |
Wyeth Corp |
Metodo de produccion proteica utilizando compuestos anti-senescencia
|
|
CA2626804A1
(en)
|
2005-11-01 |
2007-08-09 |
Abbott Biotechnology Ltd. |
Methods and compositions for diagnosing ankylosing spondylitis using biomarkers
|
|
MX2008012896A
(es)
|
2006-04-05 |
2008-10-14 |
Abbott Biotech Ltd |
Purificacion de anticuerpos.
|
|
EP2666472A3
(en)
|
2006-04-10 |
2014-04-02 |
Abbott Biotechnology Ltd |
Uses and compositions for treatment of psoriatic arthritis
|
|
WO2007120656A2
(en)
|
2006-04-10 |
2007-10-25 |
Abbott Biotechnology Ltd. |
Uses and compositions for treatment of rheumatoid arthritis
|
|
US20080118496A1
(en)
|
2006-04-10 |
2008-05-22 |
Medich John R |
Uses and compositions for treatment of juvenile rheumatoid arthritis
|
|
WO2007120626A2
(en)
|
2006-04-10 |
2007-10-25 |
Abbott Biotechnology Ltd. |
Uses and compositions for treatment of ankylosing spondylitis
|
|
CA2564435A1
(en)
|
2006-04-10 |
2007-10-10 |
Abbott Biotechnology Ltd. |
Methods for monitoring and treating intestinal disorders
|
|
US9605064B2
(en)
|
2006-04-10 |
2017-03-28 |
Abbvie Biotechnology Ltd |
Methods and compositions for treatment of skin disorders
|
|
EP2708242A3
(en)
|
2006-04-10 |
2014-03-26 |
Abbott Biotechnology Ltd |
Uses and compositions for treatment of ankylosing spondylitis
|
|
US7846724B2
(en)
|
2006-04-11 |
2010-12-07 |
Hoffmann-La Roche Inc. |
Method for selecting CHO cell for production of glycosylated antibodies
|
|
US20100021451A1
(en)
|
2006-06-08 |
2010-01-28 |
Wong Robert L |
Uses and compositions for treatment of ankylosing spondylitis
|
|
US20080311043A1
(en)
|
2006-06-08 |
2008-12-18 |
Hoffman Rebecca S |
Uses and compositions for treatment of psoriatic arthritis
|
|
CN103316402A
(zh)
|
2006-06-30 |
2013-09-25 |
艾伯维生物技术有限公司 |
自动注射装置
|
|
WO2008032712A1
(fr)
|
2006-09-11 |
2008-03-20 |
Immuno-Biological Laboratories Co., Ltd. |
Anticorps monoclonal et son utilisation
|
|
BRPI0716762A2
(pt)
|
2006-09-13 |
2013-09-24 |
Abbott Lab |
melhorias da cultura celular
|
|
EP2500416A1
(en)
|
2006-09-13 |
2012-09-19 |
Abbott Laboratories |
Cell culture improvements
|
|
US8911964B2
(en)
|
2006-09-13 |
2014-12-16 |
Abbvie Inc. |
Fed-batch method of making human anti-TNF-alpha antibody
|
|
NZ576133A
(en)
|
2006-10-27 |
2012-10-26 |
Abbott Biotech Ltd |
Crystalline anti-htnfalpha antibodies
|
|
US7935808B2
(en)
|
2007-03-30 |
2011-05-03 |
Abbott Laboratories |
Recombinant expression vector elements (rEVEs) for enhancing expression of recombinant proteins in host cells
|
|
DK2154244T3
(en)
|
2007-04-26 |
2017-06-12 |
Chugai Pharmaceutical Co Ltd |
CELL CULTIVATION PROCEDURE WHEN AN ACID-ENRICHED MEDIUM IS USED
|
|
WO2008150491A2
(en)
|
2007-05-31 |
2008-12-11 |
Abbott Laboratories |
BIOMARKERS PREDICTIVE OF THE RESPONSIVENESS TO TNFα INHIBITORS IN AUTOIMMUNE DISORDERS
|
|
WO2008154543A2
(en)
|
2007-06-11 |
2008-12-18 |
Abbott Biotechnology Ltd. |
Methods for treating juvenile idiopathic arthritis
|
|
UA107557C2
(xx)
*
|
2007-07-06 |
2015-01-26 |
|
Композиція антитіла офатумумабу
|
|
WO2009020654A1
(en)
|
2007-08-08 |
2009-02-12 |
Abbott Laboratories |
Compositions and methods for crystallizing antibodies
|
|
WO2009043049A2
(en)
|
2007-09-27 |
2009-04-02 |
Amgen Inc. |
Pharmaceutical formulations
|
|
US8883146B2
(en)
|
2007-11-30 |
2014-11-11 |
Abbvie Inc. |
Protein formulations and methods of making same
|
|
NZ622583A
(en)
|
2007-11-30 |
2015-08-28 |
Abbvie Biotechnology Ltd |
Protein formulations and methods of making same
|
|
WO2009073805A2
(en)
|
2007-12-04 |
2009-06-11 |
Verdezyne, Inc. |
Aglycosylated therapeutic antibodies and therapeutic antibody-encoding nucleotide sequences
|
|
BRPI0907186A2
(pt)
|
2008-01-15 |
2015-07-14 |
Abbott Gmbh & Co Kg |
Composições proteicas pulverizadas e métodos para sua produção
|
|
DE602008000796D1
(de)
|
2008-01-15 |
2010-04-22 |
Univ Utrecht Holding Bv |
Verfahren zur Bestimmung der Aminosäurensequenz von Peptiden
|
|
NZ600979A
(en)
|
2008-01-15 |
2014-01-31 |
Abbott Lab |
Improved mammalian expression vectors and uses thereof
|
|
TWI472339B
(zh)
|
2008-01-30 |
2015-02-11 |
Genentech Inc |
包含結合至ｈｅｒ２結構域ii之抗體及其酸性變異體的組合物
|
|
US20100040630A1
(en)
|
2008-03-24 |
2010-02-18 |
Aake Elden |
Methods and compositions for treating bone loss
|
|
ES2458541T5
(en)
|
2008-05-02 |
2025-08-04 |
Seagen Inc |
Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
|
|
AU2009307735B2
(en)
|
2008-10-20 |
2014-12-04 |
Abbvie Inc. |
Antibodies that bind to IL-12 and methods of purifying the same
|
|
TW201028433A
(en)
|
2008-10-20 |
2010-08-01 |
Abbott Lab |
Viral inactivation during purification of antibodies
|
|
TWI610936B
(zh)
|
2008-10-20 |
2018-01-11 |
艾伯維有限公司 |
使用蛋白質ａ親和性層析進行抗體之分離及純化
|
|
EP2362767B1
(en)
|
2008-10-29 |
2017-12-06 |
Ablynx N.V. |
Formulations of single domain antigen binding molecules
|
|
AU2009319856A1
(en)
|
2008-11-28 |
2010-06-03 |
Abbvie Inc. |
Stable antibody compositions and methods for stabilizing same
|
|
CN102348979A
(zh)
|
2009-03-09 |
2012-02-08 |
乔治亚大学研究基金公司 |
胃癌诊断用蛋白标记的鉴定
|
|
RU2560701C2
(ru)
|
2009-05-04 |
2015-08-20 |
Эббви Байотекнолоджи Лтд. |
Стабильные композиции с высокими концентрациями белков антител человека против tnf-альфа
|
|
BRPI1010035A2
(pt)
|
2009-06-02 |
2015-08-25 |
Regeneron Pharma |
Células deficientes em fucosilação
|
|
EP2438185A4
(en)
|
2009-06-05 |
2016-10-05 |
Momenta Pharmaceuticals Inc |
METHODS FOR MODULATING FUCOSYLATION OF GLYCOPROTEINS
|
|
WO2011028962A1
(en)
|
2009-09-04 |
2011-03-10 |
Xoma Technology Ltd. |
Antibody coformulations
|
|
AR078161A1
(es)
|
2009-09-11 |
2011-10-19 |
Hoffmann La Roche |
Formulaciones farmaceuticas muy concentradas de un anticuerpo anti cd20. uso de la formulacion. metodo de tratamiento.
|
|
CN107496917B
(zh)
|
2010-02-26 |
2021-06-11 |
诺沃—诺迪斯克有限公司 |
包含稳定抗体的组合物
|
|
US9072668B2
(en)
|
2010-03-09 |
2015-07-07 |
Janssen Biotech, Inc. |
Non-aqueous high concentration reduced viscosity suspension formulations of antibodies
|
|
BR112012030530A2
(pt)
|
2010-05-18 |
2022-12-20 |
Abbvie Inc |
Aparelho e processo para purificação de proteínas
|
|
SG10201710439UA
(en)
|
2010-05-25 |
2018-01-30 |
Genentech Inc |
Methods of purifying polypeptides
|
|
HUE039740T2
(hu)
|
2010-06-03 |
2019-01-28 |
Abbvie Biotechnology Ltd |
Alkalmazások és készítmények hidradenitis suppurativa (HS) kezelésére
|
|
CA2810909A1
(en)
|
2010-09-20 |
2012-03-29 |
Abbvie Inc. |
Purification of antibodies using simulated moving bed chromatography
|
|
US20120258496A1
(en)
|
2010-09-27 |
2012-10-11 |
Boehringer Ingelheim International Gmbh |
Production of low fucose antibodies in h4-ii-e rat cells
|
|
JP6023715B2
(ja)
|
2010-10-11 |
2016-11-09 |
アッヴィ・バハマズ・リミテッド |
タンパク質の精製方法
|
|
AU2011325974B2
(en)
|
2010-11-11 |
2016-10-27 |
Abbvie Biotechnology Ltd. |
Improved high concentration anti-TNFalpha antibody liquid formulations
|
|
MX345399B
(es)
|
2010-12-28 |
2017-01-30 |
Chugai Pharmaceutical Co Ltd |
Metodo de cultivo de celulas animales.
|
|
EP2702077A2
(en)
|
2011-04-27 |
2014-03-05 |
AbbVie Inc. |
Methods for controlling the galactosylation profile of recombinantly-expressed proteins
|
|
CN103501825B
(zh)
|
2011-05-02 |
2017-03-15 |
免疫医疗公司 |
用于小体积施用的同种异型选择的抗体的超滤浓缩
|
|
CA2838695C
(en)
|
2011-07-01 |
2017-02-14 |
Amgen Inc. |
Mammalian cell culture
|
|
GB201112429D0
(en)
|
2011-07-19 |
2011-08-31 |
Glaxo Group Ltd |
Antigen-binding proteins with increased FcRn binding
|
|
AU2012318590B2
(en)
|
2011-10-04 |
2017-05-18 |
Expression Pathology, Inc. |
SRM/MRM assay for the ephrin type-A receptor 2 protein
|
|
HK1200464A1
(en)
|
2011-10-24 |
2015-08-07 |
Abbvie Inc. |
Immunobinders directed against tnf
|
|
US20140288278A1
(en)
|
2011-10-31 |
2014-09-25 |
Joseph Nti-Gyabaah |
Chromatography process for resolving heterogeneous antibody aggregates
|
|
WO2013114164A1
(en)
|
2012-01-30 |
2013-08-08 |
Dr. Reddy's Laboratories Limited |
Method for obtaining glycoprotein composition with increased afucosylation content
|
|
WO2013114165A1
(en)
|
2012-01-30 |
2013-08-08 |
Dr Reddy's Laboratories Limited |
Process of obtaining glycoprotein composition with increased afucosylation content
|
|
US9505833B2
(en)
|
2012-04-20 |
2016-11-29 |
Abbvie Inc. |
Human antibodies that bind human TNF-alpha and methods of preparing the same
|
|
US9067990B2
(en)
|
2013-03-14 |
2015-06-30 |
Abbvie, Inc. |
Protein purification using displacement chromatography
|
|
US9181572B2
(en)
|
2012-04-20 |
2015-11-10 |
Abbvie, Inc. |
Methods to modulate lysine variant distribution
|
|
US9334319B2
(en)
|
2012-04-20 |
2016-05-10 |
Abbvie Inc. |
Low acidic species compositions
|
|
WO2013176754A1
(en)
|
2012-05-24 |
2013-11-28 |
Abbvie Inc. |
Novel purification of antibodies using hydrophobic interaction chromatography
|
|
WO2013186230A1
(en)
|
2012-06-12 |
2013-12-19 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical formulation for a therapeutic antibody
|
|
US9512214B2
(en)
|
2012-09-02 |
2016-12-06 |
Abbvie, Inc. |
Methods to control protein heterogeneity
|
|
AU2013312300A1
(en)
|
2012-09-07 |
2015-04-16 |
Coherus Biosciences, Inc. |
Stable aqueous formulations of adalimumab
|
|
JP5874587B2
(ja)
|
2012-09-10 |
2016-03-02 |
株式会社島津製作所 |
アミノ酸配列解析方法及び装置
|
|
NO2760138T3
(enExample)
|
2012-10-01 |
2018-08-04 |
|
|
|
CN104822826B
(zh)
|
2012-10-15 |
2019-04-30 |
百时美施贵宝公司 |
用于蛋白产生的哺乳动物细胞培养过程
|
|
US9844594B2
(en)
|
2012-12-18 |
2017-12-19 |
Merck Sharp & Dohme Corp. |
Liquid formulations for an anti-TNF α antibody
|
|
US9452138B2
(en)
|
2012-12-28 |
2016-09-27 |
Abbott Cardiovascular Systems Inc. |
Delivery of biologic therapeutics
|
|
US9217168B2
(en)
|
2013-03-14 |
2015-12-22 |
Momenta Pharmaceuticals, Inc. |
Methods of cell culture
|
|
AU2013384204B2
(en)
|
2013-03-14 |
2017-03-16 |
Abbvie Inc. |
Low acidic species compositions and methods for producing and using the same
|
|
US20140271633A1
(en)
|
2013-03-14 |
2014-09-18 |
Abbvie Inc. |
Mammalian cell culture performance through surfactant supplementation of feed media
|
|
JP6465794B2
(ja)
|
2013-04-25 |
2019-02-06 |
株式会社カネカ |
Ｆａｂ型抗体の分泌量を増大できるＦｄ鎖遺伝子又はＬ鎖遺伝子
|
|
TW201446961A
(zh)
|
2013-05-06 |
2014-12-16 |
Abbvie Inc |
用於細胞培養之組合物及其使用方法
|
|
AR096713A1
(es)
|
2013-06-25 |
2016-01-27 |
Cadila Healthcare Ltd |
Proceso de purificación para anticuerpos monoclonales
|
|
WO2015051310A2
(en)
|
2013-10-03 |
2015-04-09 |
Bioanalytix, Inc. |
Mass spectrometry-based method for identifying and maintaining quality control factors during the development and manufacture of a biologic
|
|
WO2015057910A1
(en)
|
2013-10-16 |
2015-04-23 |
Oncobiologics, Inc. |
Buffer formulations for enhanced antibody stability
|
|
US9085618B2
(en)
|
2013-10-18 |
2015-07-21 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same
|
|
WO2015140700A1
(en)
|
2014-03-19 |
2015-09-24 |
Dr. Reddy's Laboratories Limited |
Cell culture process
|
|
HUE029849T2
(en)
*
|
2014-05-23 |
2017-04-28 |
Ares Trading Sa |
Liquid pharmaceutical composition
|
|
HUP1400510A1
(hu)
|
2014-10-28 |
2016-05-30 |
Richter Gedeon Nyrt |
Gyógyászati TNFalfa ellenes antitest készítmény
|
|
CN105044222B
(zh)
|
2014-12-19 |
2017-09-12 |
浙江辉肽生命健康科技有限公司 |
生物活性多肽的分析测试和鉴定方法
|
|
US10696735B2
(en)
|
2015-01-21 |
2020-06-30 |
Outlook Therapeutics, Inc. |
Modulation of charge variants in a monoclonal antibody composition
|
|
EP3250598A1
(en)
|
2015-01-28 |
2017-12-06 |
Mabxience S.A. |
Pharmaceutical formulations for anti-tnf-alpha antibodies
|
|
CN105779394B
(zh)
|
2015-03-20 |
2020-03-24 |
广东东阳光药业有限公司 |
一种降低抗体酸性峰含量和改良抗体糖型的细胞培养方法
|
|
WO2017120359A1
(en)
|
2016-01-06 |
2017-07-13 |
Oncobiologics, Inc. |
Reduction of high molecular weight species, acidic charge species, and fragments in a monoclonal antibody composition
|
|
EP3400241B1
(en)
|
2016-01-06 |
2020-07-22 |
Outlook Therapeutics, Inc. |
Modulation of afucosylated species in a monoclonal antibody composition
|
|
EP3411401A1
(en)
|
2016-02-03 |
2018-12-12 |
Oncobiologics, Inc. |
Buffer formulations for enhanced antibody stability
|
|
EP3411719A1
(en)
|
2016-02-04 |
2018-12-12 |
Oncobiologics, Inc. |
Methods for identifying and analyzing amino acid sequences of proteins
|